GENERATION, TRAPPING AND FATE OF ALKYLIDENECARBENE-IODONIUM YLIDES FROM THE ADDITION OF NaN3 TO ALKYNYLPHENYLIODONIUM TOSYLATES

DOI: 10.1016/S0040-4039(00)82069-9

Source and publish data:

Tetrahedron Letters p. 1887 - 1890 (1988)

Update date:2022-08-17

Topics:

Authors:

Kitamura, Tsugio

Stang, Peter J.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4039(00)82069-9

Addition of NaN3 to RC<*>CIPh(1+)*OTs(1-) results in novel alkylidenecarbene-iodonium ylides, 5, R(N3)C=C=IPh, that by either protonation, ylide transfer or insertion of the derived carbene R(N3)C=C: give unique functionalized vinyl azides.

Full text of DOI:10.1016/S0040-4039(00)82069-9

Products guided by the article

Product name:Iodobenzene

Cas No:591-50-4

R&D Labs maybe for 591-50-4

Tianjin Boron PharmaTech Co.,Ltd.(expird)

Contact:86-022-59845187

Address:B9-401, Tianda Science Park,No.80,4th Avenue,TEDA,Tianjin, China
Xi'an Tizan Tech & Industry Co., Ltd.

Contact:86-18629066522

Address:C3009 TANG FENG INTERNATIONAL PLAZA, NO.18 FENGHUI NAN ROAD, XI'AN HIGH TECH ZONE, 710075 CHINA.
NEW FORTUNE INDUSTRIAL CO.,LTD.

website:http://newfortune.lookchem.com/

Contact:+86-25-8645-9456

Address:C4-105 GREEN ISLAND FLOWER TOWN
Shanghai KFSL Pharmaceutical Technology Co.,Ltd.

Contact:+86-21-39971718

Address:859 jiadingchengliu shanghai
Hotechem Shanghai Co., Ltd

Contact:13120882795；+86-21-34621078;+86-021-31122318

Address:Suite 2,No.2715 Longwu Road

Relevant to this article

Silver-modulated SiO₂-supported copper catalysts for selective hydrogenation of dimethyl oxalate to ethylene glycol

Doi:10.1016/j.jcat.2013.07.006
(2013)
Doi:10.1557/JMR.2000.0207
(1929)
Cyclohexadienyl uranium complexes

Doi:10.1016/0022-328X(90)80235-R
(1990)
Peculiarities of electronic, phonon and magnon subsystems of lanthanum and samarium tetraborides

Doi:10.1016/j.jallcom.2015.06.101
(2015)
Highly value-added utilization of H₂S in Na₂SO₃solution over Ca-CdS nanocrystal photocatalysts

Doi:10.1039/d0cc05894g
(2020)
Process development for a key synthetic intermediate of LY2140023, a clinical candidate for the treatment of schizophrenia

Doi:10.1021/op100325h
(2011)

Article Doi